These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7477739)

  • 1. Therapeutic effects of endothelin receptor antagonists in stroke.
    Barone FC; Willette RN; Yue TL; Feurestein G
    Neurol Res; 1995 Aug; 17(4):259-64. PubMed ID: 7477739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of endothelial function in the pathogenesis of stroke: the importance of endothelin.
    Volpe M; Cosentino F
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S45-48. PubMed ID: 10976781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection.
    Clozel M; Watanabe H
    Life Sci; 1993; 52(9):825-34. PubMed ID: 8437512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection.
    Feuerstein G; Gu JL; Ohlstein EH; Barone FC; Yue TL
    Peptides; 1994; 15(3):467-9. PubMed ID: 7937321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelins and the cerebral circulation.
    Salom JB; Torregrosa G; Alborch E
    Cerebrovasc Brain Metab Rev; 1995; 7(2):131-52. PubMed ID: 7669492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.
    Saavedra JM
    Cell Mol Neurobiol; 2005 Jun; 25(3-4):485-512. PubMed ID: 16075377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
    Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
    Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat.
    Chuquet J; Benchenane K; Toutain J; MacKenzie ET; Roussel S; Touzani O
    Stroke; 2002 Dec; 33(12):3019-25. PubMed ID: 12468806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an endothelin ET(A)-receptor antagonist, S-0139, on cerebral vasospasm and behavioral changes in dogs intracisternally administered endothelin-1.
    Sato S; Yonetani Y; Fujimoto M; Kita T; Kubo K; Nakashima T
    Life Sci; 1998; 62(13):PL191-7. PubMed ID: 9519805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
    Zimmermann M; Seifert V
    Zentralbl Neurochir; 1996; 57(3):143-9. PubMed ID: 8967274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm?
    Cosentino F; Katusić ZS
    Stroke; 1994 Apr; 25(4):904-8. PubMed ID: 8160238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelins activate phospholipase A2 in brain capillary endothelial cells.
    Vigne P; Frelin C
    Brain Res; 1994 Jul; 651(1-2):342-4. PubMed ID: 7922585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm.
    Zuccarello M; Boccaletti R; Romano A; Rapoport RM
    Stroke; 1998 Sep; 29(9):1924-9. PubMed ID: 9731620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin and subarachnoid hemorrhage: an overview.
    Zimmermann M; Seifert V
    Neurosurgery; 1998 Oct; 43(4):863-75; discussion 875-6. PubMed ID: 9766314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelins: a role in cerebrovascular disease?
    Cardell LO; Uddman R; Edvinsson L
    Cephalalgia; 1994 Aug; 14(4):259-65. PubMed ID: 7954753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental approaches to evaluate endothelin-A receptor antagonists.
    Vatter H; Zimmermann M; Seifert V; Schilling L
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):277-86. PubMed ID: 15319806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of endothelin and endothelin antagonists in traumatic brain injury: a review of the literature.
    Maegele M; Wafaisade A; Peiniger S; Braun M
    Neurol Res; 2011 Mar; 33(2):119-26. PubMed ID: 21801586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endothelin in experimental cerebral vasospasm.
    Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP
    Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of endothelin receptor antagonists in experimental stroke.
    Patel TR; Galbraith SL; McAuley MA; Doherty AM; Graham DI; McCulloch J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S412-5. PubMed ID: 8587430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.